What can patients with atopic dermatitis expect in terms of long-term efficacy and sustained symptom control with lebrikizumab treatment?
Featuring Mona Shahriari, MD |
Dermatologist, Yale University School of Medicine
Central CT Dermatology
Cromwell, CT
Related Media
Powered by Polaris TM